Pierre‐François Laterre

1994–2025 年に発表

別表記
Pierre-François Laterre · Pierre François Laterre
136
論文数
25,946
被引用数
78
h 指数
133
i10 指数

被引用数

Pierre‐François Laterre の年別被引用数1936 年: 被引用 1 件1973 年: 被引用 1 件1977 年: 被引用 1 件1978 年: 被引用 2 件1979 年: 被引用 1 件1980 年: 被引用 1 件1983 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1988 年: 被引用 3 件1990 年: 被引用 1 件1992 年: 被引用 3 件1993 年: 被引用 2 件1996 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 3 件1999 年: 被引用 3 件2000 年: 被引用 7 件2001 年: 被引用 39 件2002 年: 被引用 77 件2003 年: 被引用 182 件2004 年: 被引用 212 件2005 年: 被引用 196 件2006 年: 被引用 206 件2007 年: 被引用 198 件2008 年: 被引用 197 件2009 年: 被引用 257 件2010 年: 被引用 177 件2011 年: 被引用 178 件2012 年: 被引用 193 件2013 年: 被引用 182 件2014 年: 被引用 183 件2015 年: 被引用 113 件2016 年: 被引用 125 件2017 年: 被引用 140 件2018 年: 被引用 122 件2019 年: 被引用 456 件2020 年: 被引用 569 件2021 年: 被引用 686 件2022 年: 被引用 528 件2023 年: 被引用 425 件2024 年: 被引用 623 件2025 年: 被引用 297 件2026 年: 被引用 10 件2027 年: 被引用 1 件1937〜1972 年は被引用が無いため表示していません1974〜1976 年は被引用が無いため表示していません1981〜1982 年は被引用が無いため表示していません1984 年は被引用が無いため表示していません1987 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません1991 年は被引用が無いため表示していません1994〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,213 件、この内訳の 22.4%フランス: 引用元論文 644 件、この内訳の 6.5%イギリス: 引用元論文 625 件、この内訳の 6.3%中国: 引用元論文 576 件、この内訳の 5.8%ドイツ: 引用元論文 506 件、この内訳の 5.1%カナダ: 引用元論文 478 件、この内訳の 4.8%イタリア: 引用元論文 405 件、この内訳の 4.1%オランダ: 引用元論文 398 件、この内訳の 4%ベルギー: 引用元論文 378 件、この内訳の 3.8%オーストラリア: 引用元論文 377 件、この内訳の 3.8%スペイン: 引用元論文 301 件、この内訳の 3.1%日本: 引用元論文 251 件、この内訳の 2.5%
0%22.4%その他 27.8%

分野

  • Medicine74.3%
  • Biochemistry, Genetics and Molecular Biology9.2%
  • Immunology and Microbiology9%
  • Nursing1.8%
  • Neuroscience1.3%
  • Engineering1%
  • その他3.4%

トピック

  • Sepsis Diagnosis and Treatment11.5%
  • Immune Response and Inflammation4.3%
  • Respiratory Support and Mechanisms3.1%
  • Intensive Care Unit Cognitive Disorders2.7%
  • Nosocomial Infections in ICU2.5%
  • Acute Kidney Injury Research2.5%
  • その他73.4%

共著者

全論文

検索で開く
  1. The SOFA score—development, utility and challenges of accurate assessment in clinical trials

    著者: , , , - Critical Care 2019 被引用: 969

  2. Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2013 被引用: 795

  3. Hydrocortisone Therapy for Patients with Septic Shock

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2008 被引用: 2,109

  4. Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

    著者: , , , , , , , , , , - New England Journal of Medicine 2001 被引用: 6,149

  5. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julien Bohé, Gaëtan Plantefève, Saadalla Nseir, Jean‐Yves Lefrant, Xavier Monnet, Laurent Papazian, Christophe Vinsonneau, Jean‐Michel Constantin, Alexandre Mebazaa, Haikel Oueslati, D. Escudero, Fernando Martínez‐Sagasti, Enrique Piacentini, Paula Ramirez Galleymore, Thierry Dugernier, David Fagnoul, Isabelle Michaux, Allan Seibert, Matti Reinikainen, Thorbjørn Grøfte, Ignacio Martín‐Loeches, John G. Laffey - The Lancet Respiratory Medicine 2023 被引用: 74

  6. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ludovic Gèrards, Phillipe Hantson, Virginie Montiel, Caroline Berghe, M Dujardin, Leslie Gielens, Suzanne Renard, Philippe G. Jorens, Pierre Asfar, Gaëtan Plantefève, Jacques Duranteau, Emmanuel Weiss, Constance Vuillard, Anne-Laure Fedou, Marine Goudelin, Bruno Evrard, Thomas Daix, Arnaud Desachy, Philippe Vignon, Anne-Aurore Duchambon, Ludmila Baudrillart, P Bourzeix, Alexandra Gay, Céline Prevost, Coralie Chalot, Isabelle Herafa, P. Engels, Martin Maëlle, Lila-Fariza Abeud, Laure Berton, Kamilė Čerlinskaitė‐Bajorė, Nicolas Deye, Marie-Céline Fournier, Tassadit Hadjam, Alexa Hollinger, Tuija Javanainen, Clément Jourdaine, Matthieu Legrand, Badr Louadah, Arthur Neuschwander, Raphaël Clère-Jehl, Julien Demiselle, Hamid Merdji, Alexandra Monnier, Emmanuelle Mercier, Stefan Kluge, Alexander Zarbock, Arthur R. H. van Zanten, Wytze Vermeijden, Tom Dormans - Intensive Care Medicine 2021 被引用: 92

  7. Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raphaël Cinotti, Pierre-Joachim Mahé, Dominique Demeure, Albane Soria, Delphine Flattrès, Gwenhaël Colin, Aihem Yehia, Jean-Claude Lacherade, Isabelle Vinatier, Christine Lebert, Yolaine Alcourt, Natacha Maguigneau, Vanessa Zinzoni, Marie-Anne Fally, Laurence Robin, Olivier Pajot, Emmanuelle Boitrou, Raphaël Favory, Julien Poissy, Anahita Rouze, Claire Delcourte, Yannick Rabouel, Julie Helms, Raphaël Clere-Jehl, Alexandra Monnier, Hamid Merdji, Samir Chenaf, Hayet Allam, Vincenta Franja, Xavier Wittebole, Philippe Hantson, Christine Colienne, Ludovic Gérard, Virginie Montiel, Diego Castanares Zapatero, Suzanne Renard, Marie France Dujardin, Caroline Berghe, Leslie Gielens - Intensive Care Medicine 2018 被引用: 109

  8. Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International Reports 2018 被引用: 107

  9. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre‐François Laterre, Didier Chochrad, Alain Dive, Frédéric Forêt, Marc A. Simon, Herbert Spapen, Jacques Créteur, Yves Bouckaert, Patrick Biston, Marc Bourgeois, Martin Nováček, Tomáš Vymazal, Petr Svoboda, Jan Pachl, Vladimír Šrámek, Michal Hanauer, Tomas Hruby, Martin Balík, Tomáš Suchý, Alain Lepape, Laurent Argaud, Frédéric Dailler, Arnaud Desachy, Christophe Guitton, Alain Mercat, Ferhat Meziani, Jean-Christophe Navellou, R. Robert, Bertrand Souweine, Jean‐Marc Tadié, Adel Maamar, Djillali Annane, Fabienne Tamion, Antoine Gros, Saad Nseir, Carole Schwebel, Gilles Francony, Jean‐Yves Lefrant, Francis Schneider, Matthias Gründling, J. Motsch, Lorenz Reill, Caroline Rolfes, Tobias Welte, Oliver A. Cornely, Frank Bloos, Maria Deja, Katrin Schmidt, Frank Wappler, Andreas Meier‐Hellmann, Apostolos Komnos, Vasileios Bekos, Vasilios Koulouras, Ioanna Soultati, Georgios Baltopoulos, Georgios Filntisis, Epaminondas Zakynthinos, Spyros Zakynthinos, Ioannis Pnevmatikos, Ildikó Krémer, Zoltán Szentkereszty, Ágnes Sárkány, Zsuzsa Marjanek, Pedro Henrique de Moura, Maria Consuelo Pintado Delgado, Juan Carlos Montejo González, Paula Ramírez, Antonio Torres Martí, Juan Carlos Valía, José A. Lorente ほか 6 名 - The Lancet Infectious Diseases 2021 被引用: 87

  10. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margot Vander Laenen, Marianne Vang, Philippe Vignon, Isabelle Vinatier, Sine Wichmann, Xavier Wittebole, Anne Louise Kjølbye, Derek C. Angus, for the SEPSIS-ACT Investigators - JAMA 2019 被引用: 140

  11. Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

    著者: , , , , , , , , , , , , , , , - Intensive Care Medicine 2020 被引用: 71

  12. Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2003 被引用: 957

  13. Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

    著者: , , , , , , , , - Critical Care Medicine 2018 被引用: 142

  14. Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 71

  15. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ram Subramanian, Frank Tacke, Dana Tomescu, Victor W. Xia, Gebhard Wagener, Cathérine Paugam‐Burtz - Transplantation 2020 被引用: 91

  16. TICACOS international: A multi-center, randomized, prospective controlled study comparing tight calorie control versus Liberal calorie administration study

    著者: , , , , , , , , - Clinical Nutrition 2020 被引用: 81

  17. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandre Mebazaa - Critical Care 2021 被引用: 79

  18. The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vasilios Koulouras, Melissa Lassig‐Smith, Pierre‐François Laterre, Katie Lei, Patricia Leung, Jean‐Yves Lefrant, Mireia Llauradó‐Serra, Ignacio Martín‐Loeches, Mohd Basri Mat Nor, Marlies Ostermann, Suzanne L. Parker, Jordi Rello, Darren M. Roberts, Michael S. Roberts, Brent Richards, Alejandro Rodríguez, Anka C. Roehr, Claire Roger, Leonardo Seoane, Mahipal Sinnollareddy, Eduardo Sousa, Dolors Soy, Anna Spring, Therese Starr, Jane Thomas, John Turnidge, Steven C. Wallis, Tricia S. Williams, Xavier Wittebole, Xanthi Zikou, Sanjoy K. Paul, Jeffrey Lipman, Max Andresen, Sónia F Baltazar, Saber Davide Barbar, Eulália Costa, D. Durand, Ricardo Freitas, Otto Frey, Yarmarly C. Guerra Valero, Margaret Haughton, Andreas Koeberer, Marin H. Kollef, Kerenaftali Klein, Ravindra L. Mehta, Cathy McKenzie, Laurent Müller, Priya Nair, Vineet Nayyar, Jenny Lisette Ordóñez Mejia, Georgia-Laura Panagou, Jody Paxton, Leah Peck, Mayukh Samanta, Jean‐Louis Vincent, Ruth Wan, Helen Young - Clinical Infectious Diseases 2020 被引用: 146

  19. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients

    著者: , , , , , , , , , , , , , , , , , , , , - EBioMedicine 2022 被引用: 99

  20. Incidence and Outcome of Subclinical Acute Kidney Injury Using penKid in Critically Ill Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 79

  21. A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tobias Welte, Anton Klingler, Romana Hochreiter, Kerstin Westritschnig - Critical Care 2017 被引用: 77

  22. sTREM-1 is a specific biomarker of TREM-1 pathway activation

    著者: , , , , , , , , , , - Cellular and Molecular Immunology 2021 被引用: 75

  23. Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

    著者: , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 被引用: 890

  24. Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

    著者: , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 被引用: 86